Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain
A robust cell-free platform technology, ribosome display in combination with cloning, expression, and purification was utilized to develop single chain Fragment variable (scFv) antibody variants as pain therapy directed at the mouse cholecystokinin B (CCK-B) receptor. Three effective CCK-B peptide-s...
Main Authors: | Adinarayana Kunamneni, Marena A. Montera, Ravi Durvasula, Sascha R. A. Alles, Sachin Goyal, Karin N. Westlund |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/11035 |
Similar Items
-
“Stapling” scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023-12-01) -
Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
by: Manuela Berto Pucca, et al.
Published: (2011-03-01) -
Development of Anti-LRRC15 Small Fragments for Imaging Purposes Using a Phage-Display ScFv Approach
by: Pierre-Emmanuel Baurand, et al.
Published: (2022-10-01) -
Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies
by: Dina Rodrigues Martins, et al.
Published: (2023-12-01) -
Chaperone-Assisted Soluble Expression of a Humanized
Anti-EGFR ScFv Antibody in E. Coli
by: Kamal Veisi, et al.
Published: (2015-12-01)